Status:
RECRUITING
Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation
Lead Sponsor:
University of Oklahoma
Conditions:
Asthma in Children
Asthma Attack
Eligibility:
All Genders
5-17 years
Phase:
EARLY_PHASE1
Brief Summary
This study aims to identify whether early administration of magnesium sulfate in moderate asthma exacerbations can potentially avoid admission, decrease length of stay in the emergency department (ED)...
Detailed Description
Patients ages 5-17 presenting to the OU Children's Hospital Emergency Department from October 2023 to July 2024 will be assigned a respiratory score (RS) upon presentation. Those with a RS between 6-9...
Eligibility Criteria
Inclusion
- Ages 5-17 years old
- Presents to the ED with a respiratory score in the "Moderate" range (6
- Parent(s)/Caregiver(s) speak English
Exclusion
- Patients with chronic medical conditions including chronic pulmonary disease (other than asthma), cerebral palsy, congenital heart disease, tracheostomy dependent, myasthenia gravis patients
- Patients who are pregnant
- Parent(s)/Caregiver(s) do not speak English
Key Trial Info
Start Date :
November 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06137040
Start Date
November 30 2023
End Date
May 31 2025
Last Update
December 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oklahoma Children's Hospital
Oklahoma City, Oklahoma, United States, 73104